Background: Signifi cant proportions of patients presenting with moderate to severe traumatic brain injuries are diagnosed as having coagulation disorder and subsequent secondary brain injury. We evaluated the incidence of coagulopathy in patient with moderate to severe traumatic brain injury in this study. Methods: A prospective study of 100 patients with moderate to severe traumatic brain injury was carried out over a period of 2 years. Platelet count (PC), Bleeding time (BT), Clotting time (CT), Prothrombin time (PT), International Normalized ratio (INR), activated partial thromboplastin time (aPTT) and Fibrin degradation product (FDP) were measured at the time of admission and 12 hourly for 7 days. Daily D-dimer evaluation for DIC was performed in those who had abnormal value in any one of these parameters. Coagulopathy was classifi ed as collectively 3 abnormal parameters. Results: Among the 100 patients, 43% had severe and 57% had moderate traumatic brain injury. Coagulopathy was detected in 63% of total patients; 76.7% (33/43) among severe traumatic brain injury and 52.7% (30/57) among moderate (p 0.013). Multivariate statistical analysis showed deranged FDP as a signifi cant individual predictor of coagulopathy among others (p<0.001, Odds ratio 166.25; 95% confi dence interval 31.7±869.7). Conclusion: Coagulopathy is common in patients with moderate to severe traumatic brain injury. Evaluation of FDP can signifi cantly predict coagulopathy in traumatic brain injury patients.
INTRODUCTION
Traumatic brain injury is a major cause of presentation to any neurosurgical centre. The outcomes of such injuries have been found to be affected by hemostatic derangements. Brain tissue is rich in thromboplastin, and activation of clotting pathways following traumatic brain injury is thought to occur leading to abnormal coagulation. 1 Many studies have suggested possible adverse effects of disseminated intravascular coagulation and other coagulopathies on outcome of the patients. [2] [3] [4] [5] [6] [7] Post-traumatic coagulopathy, in particular, appears to be linked to secondary cerebral injury. 5, 8 Although the extent of this process is yet to be elucidated fully, coagulation abnormalities are evident soon after trauma. This allows early identifi cation of patients likely to suffer secondary complications and provides an opportunity to mitigate post traumatic disseminated intravascular coagulation and related pathologies in these patients.
MATERIALS AND METHODS
This prospective longitudinal analytical study was carried out from June 2010 to May 2012 at National Institute of Neurological and Allied Science, Bansbari, Kathmandu. All patients admitted to NINAS with moderate to severe traumatic brain injuries were included in the study. Patients on anti-coagulants before injury and previous history of coagulopathy were excluded from the study. Nonprobability, purposive sampling technique was adopted to select the required samples.
A total of 118 consecutive patients with moderate to severe traumatic brain injuries were enrolled in the study. Out of them, 18 patients died within 2 days of admission and hence were excluded from the study, leaving behind a cohort of 100 patients. Platelet count (PC), Bleeding time (BT), Clotting time (CT), Prothrombin time (PT), International Normalized ratio (INR), activated partial thromboplastin time (aPTT) and Fibrin degradation product (FDP) were measured at the time of admission and every 12 hourly thereafter for the fi rst 7 days of admission. Patients with features suggestive of rapidly progressing coagulopathy were evaluated in the line of DIC by evaluating D-dimer every 24 hour. Any kind of therapeutic interventions for the management of the patient in the due course of study period were provided without bias. Such patients were still a part of the study thereafter.
Data were edited and analyzed using descriptive and inferential statistics. SPSS 
RESULTS
Among the 100 patients included in the study, age of patients ranged from 7 years to 77 years with mean age being 32.7±14.5 years. Males comprised 84% of the population with a signifi cant preponderance in all age groups. Severity of traumatic brain injury was graded according to the GCS of the patient at the time of presentation. GCS of 3 to 8 were grouped as severe and GCS of 9 to 12 as moderate traumatic brain injury. Among the patients included in the study, 43 had severe and 57 had moderate traumatic brain injury.
Abnormality of at least one hemostatic parameter among BT, CT, PT/INR, aPTT, Platelet Count and FDP and D-dimer, was seen in 73 patients, however, only 63 developed coagulopathy as evident by abnormality of any three of the parameters collectively.
Only 2 patients developed prolonged BT during the study period and both of them developed coagulopathy subsequently. However, the correlation of raised BT and development of coagulopathy was not significant (p=0.529). Twelve patients developed prolonged CT and all them developed coagulopathy which was statistically signifi cant (p=0.03). Sixty three patients developed prolonged PT out of which 54 (85.7%) developed coagulopathy (p<0.001) while 9 had other haemostatic parameters within normal limit. Nineteen patients developed prolonged aPTT and all of them developed coagulopathy which was statistically signifi cant (p<0.001). Thrombocytopenia was noted in 59 patients among whom 55 (93.2%) developed coagulopathy and the correlation was statistically signifi cant with p<0.001. FDP levels were raised in 59 patients and 57 (96.6%) of them developed coagulopathy (p < 0.001). D-dimer was evaluated in 73 patients who had at least one abnormal haemostatic parameter abnormality. Out of the 73 patients, 56 (76.7%) had deranged D-dimer out of which 55 (98.2%) developed coagulopathy which was statistically signifi cant with p<0.001 as shown in Table 1 .
Among the haemostatic parameters mentioned above, CT, PT, aPTT, Platelet Count, FDP and D-dimer were found to be signifi cant predictors of coagulopathy. Multivariate statistical analysis among these parameters however showed FDP as a significant individual predictor of coagulopathy among others (p<0.001, Odds ratio 166.25; 95% confi dence interval 31.7±869.7).
Abnormality in any three of the haemostatic parameters, defi ned as Coagulopathy, were found in 63 patients. Among the patients with coagulopathy, 34.9% of patient developed coagulopathy within 24 hours of admission. Coagulopathy was diagnosed from the time of admission to up to 5 days from admission during the study period. Table 2 shows the time of diagnosis of coagulopathy in the cohort of patient studied.
Among the patients developing coagulopathy, 34.9% (n=22) were in 20-30 years age group. When the age groups of patients were analyzed for development of coagulopathy, no signifi cant correlation was found (p=0.735). Table 3 shows the development of coagulopathy in different age groups. Coagulopathy was equally common in both the genders. Among the males, 63.1% and 62.5% of among females developed coagulopathy (p=0.964) as shown in Table 4 .
Coagulopathy was present in 76.7% of severe traumatic brain injury patients compared to 52.7% in moderate traumatic brain injury (p=0.013) as shown in Table 5 .
DISCUSSION
This prospective study included a wide range of patients, from 7 years to 77 years, and different types of head injuries. There was a striking predominance of male patients, total 84%, consistent with other studies as well. 4, 9 A study by Talving P 10 including 436 patient with traumatic brain injury showed 78% males with overall mean age of 37±20 years. Affonseca 11 had 69.1% males in her study too. Present study showed that coagulopathy was most common in age group of 20-30 as 22 patients in that age group developed coagulopathy. Coagulopathy was equally common in both genders as 63.1% of all males and 62.5% of all females developed coagulopathy.
As mild traumatic brain injuries were excluded from present study, moderate traumatic brain injury patients comprised the bulk of cohort (57%). Association of severity of traumatic brain injury with coagulopathy was found to be statistically signifi cant as 76.7% of patients with severe head injuries in present study developed coagulopathy compared to 52.5% of patients with moderate head injuries. Affonseca 11 also included moderate to severe head injuries in his study which consisted of 37.2% patients with moderated traumatic brain injury and 62.8% severe traumatic brain injury and, similar to our fi ndings, he had shown association of coagulopathy with GCS of the patient. Talving 10 , in his study of 436 patients with traumatic traumatic brain injury, has shown statistically signifi cant association of development of coagulopathy with GCS of the patient.
The incidence of coagulopathy is diffi cult to defi ne with the frequency ranging from 17% to 76% of traumatic brain injury depending upon the study group and laboratory criteria. 3, [12] [13] [14] [15] The wide variation may be due to the bias of the selection of patients, diversity of injury severities, varying criteria used to define coagulopathy, different sensitivities of the clotting tests used, different times at which coagulation was tested after injury and defi nition of coagulation abnormalities followed. Pondaag 3 defi ned coagulopathy as a fi brinogen level below 130 mg/dl and FDP values greater than 40 gm/ml. Halpern 6 defi ned coagulopathy in his study as PT above normal range of 10.3-13.4 seconds. Lozance, 4 Selladurai 8 and Olson 9 defi ned coagulopathy as a DIC score below 6. Preston 15 defi ned coagulopathy as decreased platelet counts and FDP, aPTT and PT increased from normal values. We have, in present study, defi ned coagulopathy as abnormality of three or more than three hemostatic parameters among BT, CT, PT, aPTT, FDP and D-Dimer.
Abnormality of at least one parameter was seen in 73 patients in the present study, which corroborates to the fi ndings of Selladurai 8 who found that 71% of patients had at least one hemostatic parameter abnormal. However, only 63% in our study developed coagulopathy as evidenced by abnormality of any three haemostatic parameters, compared to 38% in the study by Selladurai. 8 This could be attributed to different criteria used for diagnosis of coagulopathy. Similar to our fi ndings, Affonseca 11 observed coagulopathy in 77% of patients and that its presence was closely related to the severity of traumatic brain injury. Kuo 5 found in his study that the incidence of abnormal coagulation following traumatic brain injury was 72.1%. In patients who succumb to the injury, the incidence was 100% whereas it was 66% in those who survived. This indicates higher mortality among patients who develop coagulopathy after traumatic traumatic brain injury. An abnormality in the PT, aPTT, or Platelet count at admission was present in 55% of 253 patients studied by Stein. 7 Harhangi, 17 in his review, found that one out of three patients with traumatic brain injury developed coagulopathy.
Abnormal Platelet count and FDP levels were seen in 59% patients in our study refl ecting that these are the common parameters to be deranged in traumatic brain injury patients. In the study by Kuo, 5 59% patients had abnormal D-dimer and 24.5% had abnormal aPTT making them commonest abnormalities. Contrary to our fi ndings, they had thrombocytopenia in only 3.3% of patients. Statistically significant association between individual coagulopathy parameter and development of coagulopathy in present study was seen in patients with abnormal CT, PT, aPTT, Platelet counts, FDP and D-dimer. Multivariate study among these parameters showed that only FDP had statistically signifi cant predictive capacity for development of coagulopathy.
Lustenberger 16 found in his study that coagulopathy occurred 23.1±2.2 hours after admission and early coagulation abnormalities occurred within 12 hours of admission. He has shown that coagulopathy may ensue as late as 5 days after injury. Similarly, Talving 10 diagnosed coagulopathy on an average of 20.8 hours after admission, minimum being 10 minutes and maximum time to develop coagulopathy being 7.4 days. In this study as well, most patients with coagulopathy, 34.9%, developed it within 24 hours of admission. Coagulopathy was diagnosed from the time of admission to up to 5 days after admission in our study.
CONCLUSION
Traumatic brain injury is often complicated by presence of coagulopathy. In moderate to severe head traumatic brain injury, coagulopathy is present in about 2/3 rd of the patients. Coagulopathy was found to develop from the time of onset of injury to up to 5 days after injury. Coagulopathy was equally common in both the genders and was not affected by the mode of injury. This study showed that evaluation of FDP can signifi cantly predict coagulopathy in traumatic brain injury patients.
